[Federal Register Volume 61, Number 148 (Wednesday, July 31, 1996)]
[Notices]
[Page 39987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-19444]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 9, 1996, and published in the Federal 
Register on April 19, 1996, (61 FR 17322), Knoll Pharmaceuticals, 30 
North Jefferson Road, Whippany, New Jersey 07981, made application to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of hydromorphone (9150), a basic class of controlled 
substance listed in Schedule II.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Knoll Pharmaceuticals to 
manufacture hydromorphone is consistent with the public interest at 
this time. Therefore, pursuant to 21 U.S.C. Sec. 823 and 28 CFR 
Secs. 0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic class 
of controlled substance listed above is granted.

    Dated: July 25, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-19444 Filed 7-30-96; 8:45 am]
BILLING CODE 4410-09-M